Search Results - "Šimůnek, T"
-
1
Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone
Published in British journal of pharmacology (01-09-2008)“…Background and purpose: The clinical utility of anthracycline antineoplastic drugs is limited by the risk of cardiotoxicity, which has been traditionally…”
Get full text
Journal Article -
2
Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death
Published in British journal of cancer (01-09-2009)“…Background: Dexrazoxane (DEX, ICRF-187) is the only clinically approved cardioprotectant against anthracycline cardiotoxicity. It has been traditionally…”
Get full text
Journal Article -
3
Iron is not involved in oxidative stress‐mediated cytotoxicity of doxorubicin and bleomycin
Published in British journal of pharmacology (01-12-2006)“…Background and purpose: The anticancer drugs doxorubicin and bleomycin are well‐known for their oxidative stress‐mediated side effects in heart and lung,…”
Get full text
Journal Article -
4
Early detection of anthracycline cardiotoxicity in a rabbit model: left ventricle filling pattern versus troponin T determination
Published in Physiological research (01-01-2007)“…Anthracycline cardiotoxicity represents a serious risk of anticancer chemotherapy. The aim of the present pilot study was to compare the potential of both the…”
Get full text
Journal Article -
5
Evaluation of ECG time intervals in a rabbit model of anthracycline-induced cardiomyopathy: a useful tool for assessment of cardioprotective agents
Published in Physiological research (01-01-2007)“…The aim of this study was to analyze the ECG time intervals in the course of the development of chronic anthracycline cardiomyopathy in rabbits. Furthermore,…”
Get full text
Journal Article -
6
Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbits
Published in Pharmacological research (01-03-2005)“…Risk of cardiotoxicity is the most serious drawback of the clinical usefulness of anthracycline antineoplastic antibiotics, which however, remain among the…”
Get full text
Journal Article -
7
Safety and tolerability of repeated administration of pyridoxal 2-chlorobenzoyl hydrazone in rabbits
Published in Human & experimental toxicology (01-11-2005)“…Recently, pyridoxal 2-chlorobenzoyl hydrazone (o-108) has been identified as an effective iron chelator [Link et al., Blood 2003; 101: 4172-79]. Since chronic…”
Get more information
Journal Article -
8
Anthracycline-induced cardiotoxicity
Published in Acta medica Lékarskí fakulty Univerzity Karlovy v Hradci Králove (2000)“…Anthracycline antibiotics are among the most effective and widely used antineoplastic drugs. Their usefulness is limited by a cumulative dose-related…”
Get full text
Journal Article -
9
Cardiac troponin T following repeated administration of pyridoxal isonicotinoyl hydrazone in rabbits
Published in Physiological research (2002)“…Pyridoxal isonicotinoyl hydrazone (PIH) is a new tridentate Fe-chelating agent that should be very promising in many pathological states resulting from both an…”
Get full text
Journal Article -
10
Protein profiling in daunorubicin-induced cardiomyopathy
Published in General physiology and biophysics (01-09-2003)“…The aim of this paper was to study the protein remodelling of the left ventricle following repeated administration of either daunorubicin (DNR) or DNR in…”
Get full text
Journal Article -
11
The role of reactive oxygen and nitrogen species in cellular iron metabolism
Published in Free radical research (01-03-2006)“…The catalytic role of iron in the Haber-Weiss chemistry, which results in propagation of damaging reactive oxygen species (ROS), is well established. In this…”
Get more information
Journal Article -
12
In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity
Published in Toxicology (Amsterdam) (31-07-2007)“…Abstract Cardiac troponin T (cTnT) and troponin I (cTnI) are becoming acknowledged as useful biochemical markers of drug-induced cardiotoxicity. In this study…”
Get full text
Journal Article -
13
SIH—a novel lipophilic iron chelator—protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death
Published in Journal of molecular and cellular cardiology (01-08-2005)“…Recent evidence suggests that oxidative stress is a common denominator in many aspects of cardiovascular pathogenesis. Free cellular iron plays a crucial…”
Get full text
Journal Article -
14
Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents
Published in European journal of heart failure (01-06-2004)“…Background: Cardiac toxicity associated with chronic administration of anthracycline (ANT) antibiotics represents a serious complication of their use in…”
Get full text
Journal Article -
15
Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: A study of salicylaldehyde isonicotinoyl hydrazone (SIH)
Published in Toxicology (Amsterdam) (25-06-2007)“…Abstract Pyridoxal-derived aroylhydrazone iron chelators have been previously shown as effective cardioprotectants against chronic anthracycline…”
Get full text
Journal Article -
16
Direct administration of rutin does not protect against catecholamine cardiotoxicity
Published in Toxicology (Amsterdam) (08-01-2009)“…Abstract High levels of catecholamines are cardiotoxic and may trigger acute myocardial infarction (AMI). Similarly, the synthetic catecholamine isoprenaline…”
Get full text
Journal Article -
17
-
18
Comparison of protective effects of two iron chelating compounds – deferiprone and dexrazoxane – against chronic anthracycline cardiotoxicity
Published in Toxicology letters (05-10-2008)Get full text
Journal Article -
19
Proteomic analysis of the chronic anthracycline cardiotoxicity in rabbits
Published in Toxicology letters (05-10-2008)Get full text
Journal Article -
20
New iron chelators in anthracycline-induced cardiotoxicity
Published in Cardiovascular toxicology (01-06-2007)“…The use of anthracycline anticancer drugs is limited by a cumulative, dose-dependent cardiac toxicity. Iron chelation has long been considered as a promising…”
Get full text
Journal Article